{"id":"https://openalex.org/W2938716486","doi":"https://doi.org/10.2147/ppa.s187907","title":"Patient preferences for glucagon-like peptide-1 receptor\u2013agonist treatment attributes","display_name":"Patient preferences for glucagon-like peptide-1 receptor\u2013agonist treatment attributes","alternate_titles":[],"publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2938716486","doi":"https://doi.org/10.2147/ppa.s187907","mag":"2938716486","pmid":"https://pubmed.ncbi.nlm.nih.gov/31114170","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6483112"},"language":"en","primary_location":{"id":"doi:10.2147/ppa.s187907","doi":"https://doi.org/10.2147/ppa.s187907","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s187907","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49309","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2938716486"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=49309","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057128422","display_name":"Vivian Thuyanh Thieu","orcid":"https://orcid.org/0000-0001-9803-4134","observed_orcids":["https://orcid.org/0000-0001-9803-4134"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vivian T Thieu","raw_affiliation_strings":["Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058331086","display_name":"Susan J. Robinson","orcid":"https://orcid.org/0000-0001-5308-2933","observed_orcids":["https://orcid.org/0000-0001-5308-2933"]},"institutions":[{"id":"https://openalex.org/I4210094117","display_name":"Kennedy Martin Health Outcomes (United Kingdom)","ror":"https://ror.org/00pfazs12","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210094117"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan Robinson","raw_affiliation_strings":["Kennedy-Martin Health Outcomes (KMHO), Brighton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kennedy-Martin Health Outcomes (KMHO), Brighton, UK","institution_ids":["https://openalex.org/I4210094117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069805148","display_name":"Tessa Kennedy\u2010Martin","orcid":"https://orcid.org/0000-0001-5326-4374","observed_orcids":["https://orcid.org/0000-0001-5326-4374"]},"institutions":[{"id":"https://openalex.org/I4210094117","display_name":"Kennedy Martin Health Outcomes (United Kingdom)","ror":"https://ror.org/00pfazs12","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210094117"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tessa Kennedy-Martin","raw_affiliation_strings":["Kennedy-Martin Health Outcomes (KMHO), Brighton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kennedy-Martin Health Outcomes (KMHO), Brighton, UK","institution_ids":["https://openalex.org/I4210094117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039006946","display_name":"Kristina Secnik Boye","orcid":"https://orcid.org/0000-0002-5953-5929","observed_orcids":["https://orcid.org/0000-0002-5953-5929"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kristina S Boye","raw_affiliation_strings":["Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048081580","display_name":"Luis\u2010Emilio Garc\u00eda\u2010P\u00e9rez","orcid":"https://orcid.org/0000-0003-3840-787X","observed_orcids":["https://orcid.org/0000-0003-3840-787X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luis-Emilio Garcia-Perez","raw_affiliation_strings":["Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;"],"raw_orcid":"https://orcid.org/0000-0003-3840-787X","affiliations":[{"raw_affiliation_string":"Global Patient Outcomes and Real-World Evidence, Eli Lilly and Company, Indianapolis, IN, USA, boye_kristina_secnik@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Global Patient Outcomes and Real-world evidence, eli Lilly and Company, indianapolis, iN, USA;","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039006946"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.7757,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.6127321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"Volume 13","issue":null,"first_page":"561","last_page":"576"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8881999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.05939999967813492,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.8029999732971191},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8700000047683716},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.7979999780654907},{"id":"https://openalex.org/keywords/injection-device","display_name":"injection device","score":0.6539999842643738},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8629999756813049},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9419999718666077},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9010000228881836},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/willingness-to-pay","display_name":"willingness to pay","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6759999990463257},{"id":"https://openalex.org/keywords/patient-centered-care","display_name":"patient-centered care","score":0.9440000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.843209445476532},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.6366013288497925},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.633995771408081},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.6096203923225403},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.574187695980072},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.46644163131713867},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.45268550515174866},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.45230013132095337},{"id":"https://openalex.org/C2777364431","wikidata":"https://www.wikidata.org/wiki/Q140813","display_name":"Willingness to pay","level":2,"score":0.4366668462753296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43414029479026794},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.43359285593032837},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.428627610206604},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.42785540223121643},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3599615693092346},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.35714200139045715},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20960330963134766},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17401254177093506},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.07789260149002075},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/ppa.s187907","doi":"https://doi.org/10.2147/ppa.s187907","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s187907","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49309","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5497637","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6483112","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6483112","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6483112/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Prefer Adherence","raw_type":"Text"},{"id":"pmid:31114170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31114170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient preference and adherence","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:3df7d3ed54f642ebbeef6dacb9645075","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3df7d3ed54f642ebbeef6dacb9645075","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Patient Preference and Adherence, Vol Volume 13, Pp 561-576 (2019)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/45178","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/patient-preferences-for-glucagon-like-peptide-1-receptor-agonist-treat-peer-reviewed-article-PPA","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/ppa.s187907","doi":"https://doi.org/10.2147/ppa.s187907","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s187907","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49309","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2938716486.pdf","grobid_xml":"https://content.openalex.org/works/W2938716486.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1458612293","https://openalex.org/W2009830637","https://openalex.org/W2024670988","https://openalex.org/W2044053247","https://openalex.org/W2056102473","https://openalex.org/W2076583826","https://openalex.org/W2076697542","https://openalex.org/W2077568393","https://openalex.org/W2096416969","https://openalex.org/W2107680428","https://openalex.org/W2111876001","https://openalex.org/W2121619367","https://openalex.org/W2151497395","https://openalex.org/W2158350833","https://openalex.org/W2172193326","https://openalex.org/W2287520546","https://openalex.org/W2411109630","https://openalex.org/W2414217396","https://openalex.org/W2478113780","https://openalex.org/W2501592124","https://openalex.org/W2585146202","https://openalex.org/W2590405401","https://openalex.org/W2596498480","https://openalex.org/W2601280897","https://openalex.org/W2604317643","https://openalex.org/W2617272697","https://openalex.org/W2730168622","https://openalex.org/W2770768935","https://openalex.org/W2802483308","https://openalex.org/W2807155949","https://openalex.org/W2894993577","https://openalex.org/W2898986403","https://openalex.org/W2900465556","https://openalex.org/W2922465073","https://openalex.org/W4236074123","https://openalex.org/W4256525495"],"related_works":["https://openalex.org/W2096416969","https://openalex.org/W2585146202","https://openalex.org/W2590405401","https://openalex.org/W2543582919","https://openalex.org/W2478113780","https://openalex.org/W2920836114","https://openalex.org/W2107680428","https://openalex.org/W3180020031","https://openalex.org/W6976980293","https://openalex.org/W2922465073"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"importance":[2],"of":[3,9,21,112,172,218,259],"patient-centered":[4],"care":[5,276],"in":[6,33,80,166,177,229],"the":[7,19,72,85,282],"management":[8],"type":[10,171],"2":[11],"diabetes":[12],"mellitus":[13],"(T2DM)":[14],"is":[15,27],"widely":[16],"advocated.":[17],"Understanding":[18],"attributes":[20,162,192,217,255],"T2DM":[22,83],"medications":[23],"important":[24,257],"to":[25,35,43,108,213,284],"patients":[26,81,209,233],"thus":[28],"essential":[29],"for":[30,78,91,143,216,262],"effective":[31],"management,":[32],"order":[34],"limit":[36],"disease":[37],"progression.":[38],"This":[39],"literature":[40],"review":[41],"aimed":[42],"identify":[44],"studies":[45,79,140,268],"comparing":[46,121],"patient":[47,164,260,278],"preferences,":[48],"based":[49],"on":[50,203],"process":[51],"and":[52,60,64,71,156,180,244,253,273,288],"outcome":[53,254],"attributes,":[54,114,147],"between":[55,61],"GLP1-receptor":[56],"agonist":[57],"(RA)":[58],"profiles":[59,236,248],"GLP1":[62,92,95,144,150,189,238,246,263],"RA":[63,151,190,247],"insulin":[65,98,153],"profiles.":[66],"METHODS:":[67],"MEDLINE,":[68],"Embase,":[69],"PsycINFO,":[70],"Cochrane":[73],"Library":[74],"(2005-present)":[75],"were":[76,131,168,210],"searched":[77],"with":[82,240,277],"or":[84,94,117,224],"general":[86],"population":[87],"that":[88,187,208,232],"compared":[89,141,149],"preferences":[90,142,165],"RAs":[93,96,239],"versus":[97,124,152],"using":[99],"contingent":[100],"valuation,":[101],"conjoint":[102],"analysis":[103,206],"(discrete-choice":[104],"experiments":[105],"[DCEs],":[106],"willingness":[107],"pay),":[109],"rating-based":[110],"approaches":[111],"specific":[113],"standard":[115],"gamble,":[116],"time":[118],"trade-off.":[119],"Studies":[120],"drug":[122,125],"A":[123],"B":[126],"without":[127],"explicit":[128],"attribute":[129],"valuation":[130],"excluded.":[132],"RESULTS:":[133],"Ten":[134],"records":[135],"met":[136],"eligibility":[137],"criteria.":[138],"Eight":[139],"RA-":[145],"profile":[146],"one":[148,157],"glargine":[154],"profiles,":[155],"addressed":[158],"both":[159],"comparisons.":[160],"Important":[161],"driving":[163],"DCEs":[167,230],"dose":[169],"frequency,":[170],"device,":[173],"needle":[174,197],"size,":[175],"change":[176],"glycated":[178],"hemoglobin,":[179],"adverse-event":[181],"profile.":[182],"Time":[183],"trade-off":[184],"evaluations":[185],"demonstrated":[186],"weekly":[188],"injection-device":[191],"(reconstitution,":[193],"waiting":[194],"during":[195],"preparation,":[196],"handling)":[198],"had":[199],"a":[200],"measurable":[201],"impact":[202],"preference.":[204],"Willingness-to-pay":[205],"showed":[207],"more":[211],"willing":[212],"pay":[214],"extra":[215],"once-daily":[219],"liraglutide":[220],"over":[221,249],"twice-weekly":[222],"exenatide":[223],"insulin.":[225,250],"Direct":[226],"preference":[227,261],"elicitation":[228],"revealed":[231],"preferred":[234,245],"medication":[235,286],"representing":[237],"less":[241],"frequent":[242],"dosing":[243],"CONCLUSION:":[251],"Process":[252],"are":[256],"drivers":[258],"RAs.":[264],"Findings":[265],"from":[266],"patient-preference":[267],"can":[269],"inform":[270],"clinical":[271],"decision-making":[272],"help":[274],"align":[275],"values,":[279],"which":[280],"has":[281],"potential":[283],"improve":[285],"adherence":[287],"outcomes.":[289]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2938716486","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-04-25T00:00:00"}
